AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
74 hedge funds and large institutions have $453M invested in Aimmune Therapeutics in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 74 → 74 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
74
Holding in Top 10
5
Calls
–
Puts
$13K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$8.38M | |
| 3 | +$2.91M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.71M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.21M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$765K | |
| 3 | -$215K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$207K |
| 5 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$154K |